HomeInsightsStock Comparison

Ajanta Pharma Ltd vs Mankind Pharma Ltd Stock Comparison

Ajanta Pharma Ltd vs Mankind Pharma Ltd Stock Comparison

Last Updated on: Jun 27, 2025

Key Highlights

  • The Latest Trading Price of Ajanta Pharma Ltd is ₹ 2580 as of 27 Jun 09:32.
  • The P/E Ratio of Ajanta Pharma Ltd changed from 25.6 on March 2020 to 35.7 on March 2025 . This represents a CAGR of 5.70% over 6 yearsThe P/E Ratio of Mankind Pharma Ltd changed from 48.1 on March 2024 to 0 on March 2025 . This represents a CAGR of -100.00% over 2 years.
  • The Market Cap of Ajanta Pharma Ltd changed from ₹ 11921 crore on March 2020 to ₹ 32708 crore on March 2025 . This represents a CAGR of 18.32% over 6 yearsThe Market Cap of Mankind Pharma Ltd changed from ₹ 92029 crore on March 2024 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 2 years.
  • The revenue of Ajanta Pharma Ltd for the Mar '25 is ₹ 1188 crore as compare to the Dec '24 revenue of ₹ 1176 crore. This represent the growth of 1.02% The revenue of Mankind Pharma Ltd for the Mar '25 is ₹ 3333 crore as compare to the Dec '24 revenue of ₹ 3285 crore. This represent the growth of 1.43%.
  • The ebitda of Ajanta Pharma Ltd for the Mar '25 is ₹ 315.26 crore as compare to the Dec '24 ebitda of ₹ 351.27 crore. This represent the decline of -10.25% The ebitda of Mankind Pharma Ltd for the Mar '25 is ₹ 932.5 crore as compare to the Dec '24 ebitda of ₹ 903.08 crore. This represent the growth of 3.26%.
  • The net profit of Ajanta Pharma Ltd changed from ₹ 208.12 crore to ₹ 225.26 crore over 8 quarters. This represents a CAGR of 4.04% The net profit of Mankind Pharma Ltd changed from ₹ 494.19 crore to ₹ 424.65 crore over 8 quarters. This represents a CAGR of -7.30% .
  • The Dividend Payout of Ajanta Pharma Ltd changed from 25.99 % on March 2020 to 38.28 % on March 2025 . This represents a CAGR of 6.67% over 6 yearsThe Dividend Payout of Mankind Pharma Ltd changed from 31.56 % on March 2020 to 0 % on March 2025 . This represents a CAGR of -100.00% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Ajanta Pharma Ltd

  • Ajanta Pharma is a specialty pharmaceutical formulation company primarily with a well-diversified Branded Generics business spread across India, the Rest of Asia, and Africa.
  • The Company is involved in development, manufacturing and marketing of marketing of quality finished dosages in domestic and international markets.
  • It produces a comprehensive range of specialty products targeting different therapeutic segments.
  • It has strong chronic-focused product portfolio led by a first-to-market strategy and front-end presence which helps it outgrow the market. The company's business includes Branded Generics in emerging markets of Asia and Africa, Generics in the developed markets of USA and Institution sales.
  • The branded generics business is spread in India and more than 30 emerging countries across Africa, CIS, the Middle East and South East Asia.

About Mankind Pharma Ltd

  • Mankind Pharma Limited was incorporated on July 3, 1991, as a Private Limited Company with the name 'Mankind Pharma Private Limited', by the Registrar of Companies, Delhi and Haryana, at New Delhi.
  • Pursuant to conversion of Company to a Public Limited dated July 14, 2005, name of the Company was changed to 'Mankind Pharma Limited' and the RoC issued a fresh Certificate of Incorporation on April 13, 2006. The Company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations and chronic therapeutic areas across, as well as several consumer healthcare products.
  • It is present in several acute and chronic therapeutic areas in India, including anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS, vitamins /minerals / nutrients and respiratory.

Ajanta Pharma Ltd News Hub

News

Ajanta Pharma to convene AGM

Ajanta Pharma announced that the 46th Annual General Meeting(AGM) of the company will be h...

Read more

13 Jun 2025 09:37

News

Ajanta Pharma to discuss results

Ajanta Pharma will hold a meeting of the Board of Directors of the Company on 30 April 202...

Read more

22 Apr 2025 17:19

News

Ajanta Pharma Ltd spurts 2.5%, up for five straight sessions

Ajanta Pharma Ltd rose for a fifth straight session today. The stock is quoting at Rs 2786...

Read more

03 Feb 2025 13:00

News

Ajanta Pharma to conduct board meeting

Ajanta Pharma will hold a meeting of the Board of Directors of the Company on 30 January 2...

Read more

17 Jan 2025 21:11

News

Ajanta Pharma Ltd slips for fifth straight session

Ajanta Pharma Ltd dropped for a fifth straight session today. The stock is quoting at Rs 2...

Read more

26 Dec 2024 13:35

News

Ajanta Pharma Ltd soars 1.25%, up for fifth straight session

Ajanta Pharma Ltd gained for a fifth straight session today. The stock is quoting at Rs 29...

Read more

22 Nov 2024 13:00

Mankind Pharma Ltd News Hub

News

Mankind Pharma allots 57,709 equity shares under ESOP

Mankind Pharma has allotted 57,709 equity shares of face value of Re. 1/- each of the Comp...

Read more

10 Jun 2025 13:26

News

Mankind Pharma Ltd slips for fifth straight session

Mankind Pharma Ltd is down for a fifth straight session today. The stock is quoting at Rs ...

Read more

23 May 2025 13:35

News

Mankind Pharma slides after Q4 PAT drops 11% YoY to Rs 421 cr

However, revenue from operations increased 27.19% year-on-year (YoY) to Rs 3,079.37 crore ...

Read more

22 May 2025 15:37

News

Board of Mankind Pharma approves incorporation of WoS in Sri Lanka

The Board of Mankind Pharma at its meeting held on 21 May 2025 has approved the incorporat...

Read more

21 May 2025 18:52

News

Mankind Pharma allots 92,512 equity shares under ESOP

Mankind Pharma has allotted 92,512 equity shares under ESOP on 21 May 2025. Consequent to ...

Read more

21 May 2025 14:16

News

Mankind Pharma to discuss results

Mankind Pharma will hold a meeting of the Board of Directors of the Company on 21 May 2025...

Read more

09 May 2025 10:55

SWOT Analysis Of Ajanta Pharma Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Mankind Pharma Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Ajanta Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Mankind Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Ajanta Pharma Ltd and Mankind Pharma Ltd

Which company has a larger market capitalization, Ajanta Pharma Ltd or Mankind Pharma Ltd?

Market cap of Ajanta Pharma Ltd is 32,064 Cr while Market cap of Mankind Pharma Ltd is 95,036 Cr

What are the key factors driving the stock performance of Ajanta Pharma Ltd and Mankind Pharma Ltd?

The stock performance of Ajanta Pharma Ltd and Mankind Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Ajanta Pharma Ltd and Mankind Pharma Ltd?

As of June 27, 2025, the Ajanta Pharma Ltd stock price is INR ₹2567.0. On the other hand, Mankind Pharma Ltd stock price is INR ₹2302.65.

How do dividend payouts of Ajanta Pharma Ltd and Mankind Pharma Ltd compare?

To compare the dividend payouts of Ajanta Pharma Ltd and Mankind Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions